Dubinsky M - Search Results

1

MAGI2 genetic variation and inflammatory bowel disease.

McGovern DP, Taylor KD, Landers C, Derkowski C, Dutridge D, Dubinsky M, Ippoliti A, Vasiliauskas E, Mei L, Mengesha E, King L, Pressman S, Targan SR, Rotter JI. McGovern DP, et al. Among authors: dubinsky m. Inflamm Bowel Dis. 2009 Jan;15(1):75-83. doi: 10.1002/ibd.20611. Inflamm Bowel Dis. 2009. PMID: 18720471 Free PMC article.

2

Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease.

Ruemmele FM, Targan SR, Levy G, Dubinsky M, Braun J, Seidman EG. Ruemmele FM, et al. Among authors: dubinsky m. Gastroenterology. 1998 Oct;115(4):822-9. doi: 10.1016/s0016-5085(98)70252-5. Gastroenterology. 1998. PMID: 9753483

3

Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease.

Dubinsky MC, Lamothe S, Yang HY, Targan SR, Sinnett D, Théorêt Y, Seidman EG. Dubinsky MC, et al. Gastroenterology. 2000 Apr;118(4):705-13. doi: 10.1016/s0016-5085(00)70140-5. Gastroenterology. 2000. PMID: 10734022 Clinical Trial.

4

Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease.

Dubinsky MC, Ofman JJ, Urman M, Targan SR, Seidman EG. Dubinsky MC, et al. Am J Gastroenterol. 2001 Mar;96(3):758-65. doi: 10.1111/j.1572-0241.2001.03618.x. Am J Gastroenterol. 2001. PMID: 11280547

5

An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapy.

Dubinsky MC, Hassard PV, Seidman EG, Kam LY, Abreu MT, Targan SR, Vasiliauskas EA. Dubinsky MC, et al. Inflamm Bowel Dis. 2001 Aug;7(3):181-9. doi: 10.1097/00054725-200108000-00001. Inflamm Bowel Dis. 2001. PMID: 11515842 Clinical Trial.

6

6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease.

Dubinsky MC, Yang H, Hassard PV, Seidman EG, Kam LY, Abreu MT, Targan SR, Vasiliauskas EA. Dubinsky MC, et al. Gastroenterology. 2002 Apr;122(4):904-15. doi: 10.1053/gast.2002.32420. Gastroenterology. 2002. PMID: 11910342 Clinical Trial.

7

Thioguanine: a potential alternate thiopurine for IBD patients allergic to 6-mercaptopurine or azathioprine.

Dubinsky MC, Feldman EJ, Abreu MT, Targan SR, Vasiliauskas EA. Dubinsky MC, et al. Am J Gastroenterol. 2003 May;98(5):1058-63. doi: 10.1111/j.1572-0241.2003.07413.x. Am J Gastroenterol. 2003. PMID: 12809828

8

6-thioguanine can cause serious liver injury in inflammatory bowel disease patients.

Dubinsky MC, Vasiliauskas EA, Singh H, Abreu MT, Papadakis KA, Tran T, Martin P, Vierling JM, Geller SA, Targan SR, Poordad FF. Dubinsky MC, et al. Gastroenterology. 2003 Aug;125(2):298-303. doi: 10.1016/s0016-5085(03)00938-7. Gastroenterology. 2003. PMID: 12891528

9

Monitoring of AZA/6-MP treatment in children with IBD is necessary.

Dubinsky MC. Dubinsky MC. Inflamm Bowel Dis. 2003 Nov;9(6):386-8; discussion 392-3. doi: 10.1097/00054725-200311000-00007. Inflamm Bowel Dis. 2003. PMID: 14671488 No abstract available.

10

Early nodular hyperplasia of the liver occurring with inflammatory bowel diseases in association with thioguanine therapy.

Shastri S, Dubinsky MC, Fred Poordad F, Vasiliauskas EA, Geller SA. Shastri S, et al. Arch Pathol Lab Med. 2004 Jan;128(1):49-53. doi: 10.5858/2004-128-49-ENHOTL. Arch Pathol Lab Med. 2004. PMID: 14692812 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

439 results

Search Page

Filters